What is the current stock price of Metsera, Inc. (MTSR)?

As of the latest market data, Metsera, Inc. (MTSR) is trading at $70.50. The stock has seen a loss of -0.35% today.

Does Metsera, Inc. (MTSR) pay a dividend?

Based on current data, Metsera, Inc. does not have a confirmed active dividend policy.

What is the market cap of Metsera, Inc.?

The current market capitalization of Metsera, Inc. (MTSR) is approximately unavailable.

MTSR

Metsera, Inc.·Healthcare

70.50

0.353%(−0.25)

Market Closed

70.80

0.426%(+0.30)

After Hours

Last Updated: — ET

52W L: $12.3052W H: $83.86

MTSR NEWS

proactiveinvestors.co.uk

Mar 17

IP Group shares jump 9% as Metsera deal drives return to growth

Shares in IP Group PLC (LSE:IPO) rose 9% to 53.5p on Monday after the company reported net asset value per share climbing to 110.4p, with total NAV reaching £975.1 million. The recovery was driven largely by Pfizer's acquisition of Metsera, a biotechnology company developing obesity treatments.

Company Profile

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity. The company was incorporated in 2022 and is headquartered in New York, New York.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2025-01-31

Beta

1.70

Websitemetsera.com↗